Evista

Raloxifene tablets for postmenopausal osteoporosis and breast cancer. It mimics oestrogen in bone but opposes it in breast tissue.

Dosage

Pack size

Evista is the reference name. You receive a generic with the same active ingredient and strength.

Supply requirements for Evista depend on the medicine and destination. The fulfilment partner must confirm them before accepting an order.

Evista details

Conditions: Postmenopausal Osteoporosis · Breast Cancer
Alternative names: raloxifene hydrochloride
Therapeutic class: Selective Oestrogen Receptor Modulator (SERM)
Pharmacological class: Oestrogen Agonist/Antagonist
Contraindications: history of venous thromboembolism; pregnancy; prolonged immobilisation
Minor side effects: hot flushes; leg cramps; headache
Moderate side effects: peripheral oedema; sweating; joint pain
Dosage forms: Tablet
Administration route: Oral use
Supply category: Prescription-only medicine (POM)
Originator: Eli Lilly
Onset Time: 2–4 weeks
Duration: 24 hours
Storage instructions: Store below 25°C.
Drug interactions: Cholestyramine; Warfarin; Oestrogens
Age restrictions: Approved for postmenopausal adult females.

Serious side effects

deep vein thrombosis, requires immediate medical attention; stroke, requires immediate medical attention

Patient summary

Raloxifene tablets for postmenopausal osteoporosis and breast cancer. It mimics oestrogen in bone but opposes it in breast tissue.

Mechanism of action

Acts as an oestrogen agonist on bone, keeping mineral density intact, but as an antagonist in breast tissue to limit cellular proliferation.

Pregnancy and breastfeeding

Pregnancy: Highly contraindicated. Risk of fetal anomalies. Breastfeeding: Contraindicated.

Evista names the medicine you are looking for. What ships is a generic version of it.

A generic containing Raloxifene at the strength you pick.
Which generic brand and maker ships depends on stock and destination.
Check the active ingredient, strength, form, pack, seal, batch and expiry when it arrives.